These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Structure-Based Evolution of G Protein-Biased μ-Opioid Receptor Agonists. Wang H; Hetzer F; Huang W; Qu Q; Meyerowitz J; Kaindl J; Hübner H; Skiniotis G; Kobilka BK; Gmeiner P Angew Chem Int Ed Engl; 2022 Jun; 61(26):e202200269. PubMed ID: 35385593 [TBL] [Abstract][Full Text] [Related]
5. To probe interaction of morphine and IBNtxA with 7TM and 6TM variants of the human μ-opioid receptor using all-atom molecular dynamics simulations with an explicit membrane. Sader S; Anant K; Wu C Phys Chem Chem Phys; 2018 Jan; 20(3):1724-1741. PubMed ID: 29265141 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor. Mafi A; Kim SK; Goddard WA Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16346-16355. PubMed ID: 32601232 [TBL] [Abstract][Full Text] [Related]
7. Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis. Lipiński PFJ; Kosson P; Matalińska J; Roszkowski P; Czarnocki Z; Jarończyk M; Misicka A; Dobrowolski JC; Sadlej J Molecules; 2019 Feb; 24(4):. PubMed ID: 30791394 [TBL] [Abstract][Full Text] [Related]
8. Structural basis of μ-opioid receptor targeting by a nanobody antagonist. Yu J; Kumar A; Zhang X; Martin C; Van Holsbeeck K; Raia P; Koehl A; Laeremans T; Steyaert J; Manglik A; Ballet S; Boland A; Stoeber M Nat Commun; 2024 Oct; 15(1):8687. PubMed ID: 39384768 [TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics of fentanyl bound to μ-opioid receptor. Lipiński PFJ; Jarończyk M; Dobrowolski JC; Sadlej J J Mol Model; 2019 May; 25(5):144. PubMed ID: 31053968 [TBL] [Abstract][Full Text] [Related]
10. Computational insights into the G-protein-biased activation and inactivation mechanisms of the μ opioid receptor. Cheng JX; Cheng T; Li WH; Liu GX; Zhu WL; Tang Y Acta Pharmacol Sin; 2018 Jan; 39(1):154-164. PubMed ID: 29188799 [TBL] [Abstract][Full Text] [Related]
12. Exploring the structure of opioid receptors with homology modeling based on single and multiple templates and subsequent docking: a comparative study. Bera I; Laskar A; Ghoshal N J Mol Model; 2011 May; 17(5):1207-21. PubMed ID: 20661609 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist. Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957 [TBL] [Abstract][Full Text] [Related]
14. Ligand interaction, binding site and G protein activation of the mu opioid receptor. Cui X; Yeliseev A; Liu R Eur J Pharmacol; 2013 Feb; 702(1-3):309-15. PubMed ID: 23415745 [TBL] [Abstract][Full Text] [Related]
15. Molecular modeling of salsolinol, a full G Berríos-Cárcamo P; Rivera-Meza M; Herrera-Marschitz M; Zapata-Torres G Chem Biol Drug Des; 2019 Aug; 94(2):1467-1477. PubMed ID: 30920734 [TBL] [Abstract][Full Text] [Related]
16. Molecular recognition of morphine and fentanyl by the human μ-opioid receptor. Zhuang Y; Wang Y; He B; He X; Zhou XE; Guo S; Rao Q; Yang J; Liu J; Zhou Q; Wang X; Liu M; Liu W; Jiang X; Yang D; Jiang H; Shen J; Melcher K; Chen H; Jiang Y; Cheng X; Wang MW; Xie X; Xu HE Cell; 2022 Nov; 185(23):4361-4375.e19. PubMed ID: 36368306 [TBL] [Abstract][Full Text] [Related]
17. Probing Allosteric Regulation Mechanism of W7.35 on Agonist-Induced Activity for μOR by Mutation Simulation. Zhang F; Chen X; Chen J; Xu Y; Li S; Guo Y; Pu X J Chem Inf Model; 2022 Nov; 62(21):5120-5135. PubMed ID: 34779608 [TBL] [Abstract][Full Text] [Related]
18. Ligand based conformational space studies of the μ-opioid receptor. Sena DM; Cong X; Giorgetti A Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129838. PubMed ID: 33373630 [TBL] [Abstract][Full Text] [Related]
19. Ligand recognition in mu opioid receptor: experimentally based modeling of mu opioid receptor binding sites and their testing by ligand docking. Sagara T; Egashira H; Okamura M; Fujii I; Shimohigashi Y; Kanematsu K Bioorg Med Chem; 1996 Dec; 4(12):2151-66. PubMed ID: 9022978 [TBL] [Abstract][Full Text] [Related]
20. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints. Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]